AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $414,000 | -56.5% | 83,321 | -35.2% | 0.00% | -100.0% |
| Q3 2016 | $951,000 | +97.3% | 128,513 | +45.7% | 0.00% | – |
| Q2 2016 | $482,000 | -31.3% | 88,202 | +6.2% | 0.00% | -100.0% |
| Q1 2016 | $702,000 | -30.1% | 83,055 | -19.8% | 0.00% | 0.0% |
| Q4 2015 | $1,005,000 | -52.1% | 103,564 | -30.9% | 0.00% | -50.0% |
| Q3 2015 | $2,096,000 | -4.2% | 149,823 | -3.1% | 0.00% | 0.0% |
| Q2 2015 | $2,187,000 | +23.4% | 154,581 | -5.1% | 0.00% | 0.0% |
| Q1 2015 | $1,772,000 | -4.9% | 162,909 | -27.2% | 0.00% | 0.0% |
| Q4 2014 | $1,863,000 | +40.4% | 223,919 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $1,327,000 | +3059.5% | 222,948 | +1665.5% | 0.00% | – |
| Q2 2014 | $42,000 | -30.0% | 12,628 | -56.8% | 0.00% | – |
| Q1 2014 | $60,000 | +1.7% | 29,227 | +15.7% | 0.00% | – |
| Q4 2013 | $59,000 | +20.4% | 25,263 | +18.7% | 0.00% | – |
| Q3 2013 | $49,000 | +2.1% | 21,287 | +2.7% | 0.00% | – |
| Q2 2013 | $48,000 | – | 20,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |